In the news release, "WuXi PharmaTech Announces First-Quarter 2013 Results," issued earlier today by WuXi PharmaTech (Cayman) Inc. over PR Newswire, we are advised by the company that in the section titled "First-Quarter 2013 Non-GAAP Results," the ... AndhraNews.net, 2 days ago
Isotechnika Pharma Inc. (ISA.TO) Reports First Quarter 2013 Financial Results - BioSpace, 2 days ago
Antares Pharma, Inc. (ATRS) - Financial and Strategic SWOT Analysis Review - new company profile report - TransWorldNews, 1 day ago
More from: Stock Junction, CNBC...and 53 other sources
See all (73) images for "first pharma"
SYGNIS Pharma / . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. Madrid/Heidelberg, May 15, 2013 - SYGNIS Pharma AG (Frankfurt: LIO1, ISIN: DE000A1RFM03; Prime Standard) today ...Benzinga.com, 4 days ago SYGNIS licenses amplification buffer to QIAGEN MoneyExtra, 2 days ago Mountain States Health Alliance - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new company profile report TransWorldNews, 2 days ago BELLUS HEALTH INC: BELLUS Health Reports Results for First Quarter Ended March 31, 2013, and Provides Update on KIACTA(TM) Phase III Confirmatory Study 4 Traders, 3 days ago
Plethico Pharmaceuticals, a Rs.1,600 crore plus pharma giant from Indore, has suffered heavy setback during the first quarter ended March 2013 on account of FCCBs. Its consolidated net profit declined sharply by 72.1 per cent to Rs.13.24 crore from ...PharmaBiz, 4 days ago
AstraZeneca Pharma AB would be provide the first tranche of Rs 74 cr to the Indian firm in the current financial year, it added.Economic Times, 1 week ago AstraZeneca AB commits Rs 140 crore to Indian arm Deccan Herald, 1 week ago AstraZeneca to receive over Rs 140 cr grant Economic Times, 1 week ago
Glivec was the first-of-its-kind cancer drug for leukaemia patients with patent protection in nearly 40 countries.Economic Times, 1 month ago SC decision on Novartis: Boost for Indian pharma companies, poor patients Jagran Post, 1 month ago Supreme Court's verdict on Novartis' plea for patent of cancer drug expected today NDTV, 1 month ago COLUMN: SC right to reject Novartis's attempt Rediff.com, 1 month ago
Primary level packaging is the first-level product packaging such as the bottle, can, jar, tube, that contains the item soldMSN India, 1 month ago
After claiming the fruits of painstaking research by public institutions, private collaborators are now influencing pharma pricing mechanismsThe Hindu, 1 month ago
Aurobindo Pharma is pleased to announce that it is one of the first generics company to have received the tentative approval to manufacture and market its anti-AIDS combination drug Efavirenz / Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, ...Money Control, 1 month ago
No one expected, when the first major clinical trial started on Glivec in 2000, that the patients would live much beyond a couple of years.Yet, seven years later, 86 per cent of them were still alive, and 82 per cent of them had achieved a complete response to the medicine.This breakthrough treatment for chronic myeloid leukemia is just one example of how innovation-based pharmaceutical companies continue to research and discover new therapies.The decision by the Indian Supreme Court denying a ...Rediff.com, 1 month ago
Equity benchmarks opened lower, let down by metal, IT and infra stocks. However, a few FMCG and pharma stocks look supportive in the morning. At 09.19 AM, the Sensex fell 89.11 points at 19475.81, and the Nifty slipped 26.95 points at 5887.15.Money Control, 2 months ago
on your WebpageAdd Widget >Get your members hooked!